Critical Role of Macrophage Fc?R Signaling and Reactive Oxygen Species in Alloantibody-Mediated Hepatocyte Rejection.
Ontology highlight
ABSTRACT: Humoral alloimmunity negatively impacts both short- and long-term cell and solid organ transplant survival. We previously reported that alloantibody-mediated rejection of transplanted hepatocytes is critically dependent on host macrophages. However, the effector mechanism(s) of macrophage-mediated injury to allogeneic liver parenchymal cells is not known. We hypothesized that macrophage-mediated destruction of allogeneic hepatocytes occurs by cell-cell interactions requiring Fc?Rs. To examine this, alloantibody-dependent hepatocyte rejection in CD8-depleted wild-type (WT) and Fc?-chain knockout (KO; lacking all functional Fc?R) transplant recipients was evaluated. Alloantibody-mediated hepatocellular allograft rejection was abrogated in recipients lacking Fc?R compared with WT recipients. We also investigated anti-Fc?RI mAb, anti-Fc?RIII mAb, and inhibitors of intracellular signaling (to block phagocytosis, cytokines, and reactive oxygen species [ROS]) in an in vitro alloantibody-dependent, macrophage-mediated hepatocytoxicity assay. Results showed that in vitro alloantibody-dependent, macrophage-mediated hepatocytotoxicity was critically dependent on Fc?Rs and ROS. The adoptive transfer of WT macrophages into CD8-depleted Fc?R-deficient recipients was sufficient to induce alloantibody-mediated rejection, whereas adoptive transfer of macrophages from Fc?-chain KO mice or ROS-deficient (p47 KO) macrophages was not. These results provide the first evidence, to our knowledge, that alloantibody-dependent hepatocellular allograft rejection is mediated by host macrophages through Fc?R signaling and ROS cytotoxic effector mechanisms. These results support the investigation of novel immunotherapeutic strategies targeting macrophages, Fc?Rs, and/or downstream molecules, including ROS, to inhibit humoral immune damage of transplanted hepatocytes and perhaps other cell and solid organ transplants.
SUBMITTER: Zimmerer JM
PROVIDER: S-EPMC6289737 | biostudies-literature | 2018 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA